Search clinical trials for: PARP inhibitor BMN-673
Total 1899 results
-
Bristol-Myers SquibbTerminatedLeukemiaFrance, United States, Spain, Poland, Finland, Argentina, Canada, Belgium
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Bristol-Myers SquibbCompletedKidney TransplantationGermany, United States, Colombia, Austria, Netherlands, France, Switzerland, Argentina, Norway, Sweden
-
University of Southern CaliforniaBristol-Myers Squibb; National Cancer Institute (NCI); Astex Pharmaceuticals,...WithdrawnColorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Refractory Colorectal Carcinoma | CpG Island Methylator Phenotype | Metastatic Microsatellite Stable Colorectal CarcinomaUnited States
-
Bristol-Myers SquibbZai Lab (Shanghai) Co., Ltd.RecruitingCarcinoma, Non-Small-Cell LungJapan, China, Canada, Spain, Germany, Korea, Republic of, Austria, Brazil, Greece, France, United States, Italy, Argentina, Chile, Hungary, India, Turkey, Romania, Netherlands, Poland, Switzerland
-
National Cancer Institute (NCI)CompletedNeuroendocrine Carcinoma | Small Cell Carcinoma | Extensive Stage Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer AJCC v7 | Large Cell Lung CarcinomaUnited States
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited Kingdom
-
Bristol-Myers SquibbCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Salivary Gland Carcinoma | Salivary Gland Adenoid Cystic Carcinoma | Stage IV Major Salivary Gland Cancer AJCC v7 | Malignant Salivary Gland NeoplasmUnited States, Canada
-
Cinclus Pharma Holding ABCompletedPharmacokinetics | Safety Issues | Tolerability | Drug InteractionSweden
-
Global Alliance for TB Drug DevelopmentCompleted
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Polycythemia Vera | Myelofibrosis | Leukemia, Myelomonocytic, Chronic | Hypereosinophilic Syndrome | Mastocytosis | Agnogenic Myeloid MetaplasiaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedMyeloid Leukemia | Multiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Myelodysplastic Syndrome | Lymphoid LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma and other conditionsUnited States
-
AIO-Studien-gGmbHAstraZenecaTerminatedNSCLC | Non-squamous Non-small Cell Lung Cancer Stage II | Non-squamous Non-small Cell Lung Cancer Stage IIIA | Non-squamous Non-small Cell Lung Cancer Stage IIIB | Activating EGFR MutationGermany
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbPfizerCompletedNonValvular Atrial FibrillationJapan
-
Bristol-Myers SquibbPfizerCompleted
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerUnited States, Spain, Argentina, Belgium, Korea, Republic of, Japan
-
Bristol-Myers SquibbPfizerTerminatedVenous ThromboembolismUnited States, Belgium, Canada, Mexico, Netherlands
-
Bristol-Myers SquibbCompleted
-
IWK Health CentreHoffmann-La Roche; Nova Scotia Health Authority; Dalhousie University; Canadian...Completed
-
Radboud University Medical CenterBristol-Myers SquibbActive, not recruitingProstatic Neoplasms, Castration-ResistantNetherlands
-
Kristen GanjooBristol-Myers SquibbCompletedSoft Tissue SarcomaUnited States
-
ExelixisActive, not recruitingRenal Cell CarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Finland, France, Germany, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Poland, Singapore, Spain, Taiwan, United...
-
National Cancer Institute (NCI)Terminated
-
Bristol-Myers SquibbPfizerCompletedVenous ThrombosisArgentina, Australia, Canada, China, Czech Republic, India, Italy, Korea, Republic of, United States, Spain, France, Brazil, Russian Federation, Mexico, Austria, Denmark, Germany, Hungary, Israel, Portugal, Romania, Singapore, Norway, Chil... and more
-
Astellas Pharma IncCompletedArthritis, RheumatoidJapan
-
Bristol-Myers SquibbActive, not recruiting
-
Eli Lilly and CompanyNew Approaches to Neuroblastoma Therapy Consortium (NANT); Innovative Therapies...Active, not recruitingNeuroblastomaUnited States, Spain, Australia, Belgium, Japan, France, Germany, Italy, United Kingdom
-
Zydus Therapeutics Inc.Completed
-
National Cancer Institute, NaplesCompleted
-
University of UlmCAPNETZ StiftungTerminated
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease | Healthy VolunteersUnited States
-
Beth Israel Deaconess Medical CenterBristol-Myers SquibbRecruitingHidradenitis SuppurativaUnited States
-
University of California, IrvineBristol-Myers SquibbCompletedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Hormone-refractory Prostate CancerUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminated
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Bristol-Myers SquibbCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United States, Spain, France, Argentina, Canada, Poland
-
Bristol-Myers SquibbCompletedSclerodermaUnited States
-
Bristol-Myers SquibbCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedLymphoma | Metastatic Melanoma | Metastatic Renal Cell Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage III Bladder Cancer | Stage IV Bladder Cancer | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm and other conditionsUnited States
-
Massachusetts General HospitalActive, not recruiting
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
CelgeneNot yet recruitingHealthy ParticipantsUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbCompletedLymphoma | LeukemiaUnited States
-
National Cancer Institute (NCI)NRG Oncology; Radiation Therapy Oncology GroupCompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain NeoplasmUnited States, Canada, Saudi Arabia
-
Peking University First HospitalUnknown
-
ANRS, Emerging Infectious DiseasesBristol-Myers SquibbWithdrawn